EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine
2026-08-17 · 41 min · episode 53 · 8 entities
Asserted relationships
-
0.77
evidence rules-v5
Link in episode "EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine": https://nature.com/articles/s43587-020-00020-4
-
0.55
evidence rules-v5
Feed author/publisher: Mac & Sam
-
0.40
evidence rules-v5
Feed category: Technology
-
0.38
evidence rules-v5
Link in episode "EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine": https://insilico.com/
Entities found in this episode
websites 4
-
0.90
evidence rules-v5
Link in episode "EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine": https://nature.com/articles/s43587-020-00020-4
-
0.77
evidence rules-v5
Link in episode "EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine": https://nature.com/articles/s43587-020-00020-4
-
0.45
evidence rules-v5
Link in episode "EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine": https://insilico.com/
-
0.38
evidence rules-v5
Link in episode "EP 53: Ai4 Podcast - Revolutionizing Healthcare: AI in Drug Discovery | Alex Zhavoronkov, Insilico Medicine": https://insilico.com/
persons 2
-
0.70
evidence rules-v5
Feed author/publisher: Mac & Sam
-
0.55
evidence rules-v5
Feed author/publisher: Mac & Sam
companys 2
-
0.50
evidence rules-v5
Feed category: Technology
-
0.40
evidence rules-v5
Feed category: Technology
Episode description as stored
This episode was recorded live from the Ai4 conference podcast pavilion, Sam sat down with Alex Zhavoronkov, Founder & CEO of Insilico Medicine , about what it actually takes to turn AI-generated molecules into approved drugs.
What's Covered:
From Laughed-Out-of-the-Room to 33 Candidates — Alex pitched generative AI for drug design in 2015 and got dismissed. Today: 33 developmental candidates in six years, zero failed toxicity studies, and deals with Eli Lilly, Takeda, Servier, and SK Bio at a pace of nearly one per month.
The Real Bottleneck — "It's not about a story. Many people in our field love to tell a story, but they don't have a single drug in the clinic discovered by AI." Alex's direct take on separating hype from results in AI drug discovery.
A Lucky Breakthrough — The story of how Insilico stumbled onto a novel, non-opioid pain mechanism that outperformed morphine in animal testing — now targeting a $70 billion market.
Why Abu Dhabi — Not for speed, but for geopolitical neutrality. Alex explains why Insilico built a 60-person AI lab in the UAE, and how two drugs now trace their origin to the Middle East for the first time in modern history.
Quantum-Generated Drugs — A December 2025 Nature Biotechnology cover story: a molecule generated on a real IBM quantum computer, validated experimentally, with the University of Toronto.
Pharmaceutical Superintelligence vs. AGI — Where Alex thinks AI drug discovery already stands, and why he draws a hard line between a useful scientific partner and the "conscious AI God" version of AGI.
Key Quote: "In terms of pharmaceutical superintelligence, we're very close to being there. In terms of AGI - the future AI God - we're still not there, and we might never get there."
Connect with Alex:
LinkedIn: https://www.linkedin.com/in/zhavoronkov/
Insilico Medicine Website: https://insilico.com/
Alex's published manuscript about longevity medicine in the Nature journal: https://www.nature.com/articles/s43587-020-00020-4
Follow and subscribe to AsembleAI: Spotify | Apple Podcasts | Amazon Music | iHeart Radio | YouTube | Substack
#Ai4Conference #InsilicoMedicine #DrugDiscoveryAI #Longevity #AsembleAI